Polycystic Ovary Syndrome (PCOS), a hormonal disorder affecting roughly one in ten Canadian women, is increasingly recognized as a major but underdiagnosed health concern. Despite its prevalence, fewer than half of women with the condition are aware they have it, leaving many vulnerable to long-term complications.
A Silent Threat
Unlike simple ovarian cysts, PCOS is linked to infertility, pregnancy complications, and an elevated risk of heart disease. Research indicates that women with PCOS are 20–40% more likely to develop serious health problems over their lifetimes, including hypertension, kidney disease, gastrointestinal issues, eating disorders, depression, and anxiety.
Most alarming is the heightened cardiovascular risk. Women with PCOS are two to three times more likely to develop obesity, abnormal cholesterol levels, and type 2 diabetes. Cardiovascular disease—already the leading global cause of death—strikes these women 30–50% more often and three to four years earlier than average.
The Cost of Delay
PCOS often goes undiagnosed for months or even years. An international survey revealed that women frequently face dismissal or disbelief from healthcare providers, delaying both recognition and treatment. This gap in care places physical, emotional, and financial burdens on patients, disproportionately affecting women from lower-income groups.
Recognizing the Symptoms
Symptoms vary but can include irregular periods, excess facial or body hair, hair thinning, acne, oily skin, and weight gain. While there is no single diagnostic test or cure, doctors may order hormone blood tests and ultrasounds. Once diagnosed, patients are usually screened for cholesterol and glucose to monitor diabetes and heart disease risks.
Managing PCOS
Although incurable, PCOS can be managed. Experts recommend lifestyle interventions such as a balanced diet, regular exercise, adequate sleep, stress reduction, and relaxation practices like yoga or meditation. These approaches can help reduce symptoms and lower the risk of complications.
Advances in Research and Advocacy
Global efforts are underway to improve diagnosis and care. In 2023, new international guidelines emphasized personalized treatment plans combining lifestyle changes, medical therapy, and regular monitoring. In Canada, Alberta has launched a clinical pathway dedicated to PCOS recognition and treatment, while the University of Calgary’s EMBRACE research lab is advancing studies on reproductive disorders, including PCOS and gestational diabetes.
Patient involvement is central to these efforts. The EMBRACE lab collaborates with a PCOS Patient Advisory Council to co-design management tools and ensure research reflects real patient needs. Additional advocacy and research programs, such as PCOS Together in Alberta and similar initiatives in the UK and Australia, are working toward earlier detection and better interventions.
Raising Awareness
Despite nearly a century of medical recognition, PCOS remains poorly understood and often overlooked. Experts stress the urgent need for increased awareness, better diagnostic practices, and stronger advocacy to protect women’s health and improve quality of life.
YOU MAY ALSO LIKE
Global Survey Seeks New Name for PCOS to Reflect Condition’s True Impact
Metformin’s Role in PCOS: Benefits from Puberty to Long-Term Health
Study Uncovers How Fat Cells May Fuel Aggressive Breast Cancer
